Saturday 16 May 2020

Sorrento finds a coronavirus antibody that blocks viral infection 100% in preclinical lab experiments

Sorrento finds a coronavirus antibody that blocks viral infection 100% in preclinical lab experiments

Therapeutics company Sorrento has made what it believes could be a breakthrough in potential treatment of SARS-CoV-2, the virus that leads to COVID-19. The company released details of its preclinical research on Friday, announcing that it has found an antibody that provides “100% inhibition of SARS-CoV-2 virus infection of healthy cells after four days incubation.” The results are from a preclinical study that still has to undergo peer review.

Continue reading...

No comments:

Post a Comment